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Abstract
Background: Cognitive behavioural therapy (CBT) is an effective psychological treatment for major
depressive disorder, although some patients experience a return of symptoms after finishing therapy.
The ability to predict which individuals are more vulnerable to deterioration would allow for targeted
interventions to prevent short-term relapse and longer-term recurrence.
Aim: This systematic review and meta-analysis aimed to identify factors associated with an increased risk
of relapse and/or recurrence (RR) after CBT for depression.
Method: We reviewed 13 relevant papers, of which a small set of unique samples were eligible for
meta-analysis (k = 5, N = 369). Twenty-six predictor variables were identified and grouped into seven
categories: residual depressive symptoms; prior episodes of depression; cognitive reactivity; stressful life
events; personality factors; clinical and diagnostic factors; demographics.
Results: Meta-analyses indicated that residual depressive symptoms (r = 0.34 [0.10, 0.54], p = .01) and
prior episodes (r = 0.19 [0.07, 0.30], p = .002) were statistically significant predictors of RR, but cognitive
reactivity was not (r = 0.18 [−0.02, 0.36], p = .08). Other variables lacked replicated findings. On average,
33.4% of patients experienced RR after CBT.
Conclusions: Patients with the above risk factors could be offered evidence-based continuation-phase
interventions to enhance the longer-term effectiveness of CBT.
Keywords: cognitive behavioural therapy; CBT; depression; recurrence; relapse
Introduction
Depression is one of the leading causes of disability worldwide (World Health Organisation,
2017). Its incidence is steadily rising on an annual basis with considerable personal costs to
sufferers and economic costs to healthcare providers (McCrone et al., 2008). Major depressive
disorder (MDD) has been characterized as a refractory condition, with high rates of relapse and
recurrence. Approximately 50% of individuals who recovered from their first episode of depression
will have one or more further episodes within their lifetime, and this rises to 80% for individuals who
have a history of two or more prior episodes (American Psychiatric Association, 2000a). Relapse is
typically defined as a reappearance of an illness, after symptoms have remitted, but before full
recovery has occurred. In contrast, recurrence refers to a new episode of the illness after full recovery
has occurred. A number of operational definitions of depression relapse and recurrence have been
proposed by different authors (Möller et al., 2011). Some have defined recovery as the full remission
of symptoms for a period of 4 months (Rush et al., 2006), but others propose 6 months (Frank et al.,
1991) or even 12 months (Reimherr et al., 1998). According to contemporary guidelines
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(Bockting et al., 2015), relapse is defined as the return of major depressive symptoms within
12 months after initial remission of symptoms to a sub-clinical level. Recurrence denotes the onset
of a new episode of major depression, after a period of recovery (12 months of sustained remission of
symptoms). In this paper, the authors will be referring to both definitions as RR (relapse and/or
recurrence), as the evidence base focuses on both as predicted outcomes, using a variety of definitions
of each and therefore preventing clear delineation.
Cognitive behavioural therapy (CBT) is an increasingly available and effective psychological
intervention, recommended as a first-line treatment in clinical guidelines for the management
of depression (American Psychiatric Association, 2000b; National Institute for Health and
Care Excellence, 2010). Research suggests that CBT successfully treats the acute symptoms
of depression, whilst costing less than pharmacotherapy or combined psychological and
pharmacological treatment (Antonuccio et al., 1997). Furthermore, CBT has a lasting effect in
comparison with discontinued pharmacotherapy (Hollon et al., 2005) and therefore it has been
found to reduce the risk of short-term RR (Cuijpers et al., 2013a). However, some patients are
prone to RR after CBT as described in a review by Paykel (2007), where rates between studies
ranged from 10 to 49%. This variability may be due to individual differences, or variability in the
quality (e.g. competence and fidelity of treatment delivery) or intensity (e.g. duration) of
treatment. Continuation-phase interventions have also been developed to maximize the
long-term benefits of therapy; these are typically delivered once initial remission of symptoms
is observed after the end of the acute-phase of treatment. Examples include continuation-phase
CBT and mindfulness-based cognitive therapy (MBCT), which have been found to reduce the
risk of RR (Beshai et al., 2011; Cuijpers et al., 2013b). However, even with continuation-phase
CBT or MBCT, at least 29% of cases experience a relapse within a year or so (Piet and Hougaard,
2011; Scott et al., 2003). Therefore, it is clear that identifying individuals at higher risk of RR is
an important challenge, as enduring depression symptoms may require further treatment and
continue to incur personal, financial and societal costs.
There is a breadth of research suggesting that demographic and clinical variables are
associated with depressive RR after treatments including pharmacotherapy, interpersonal
psychotherapy, MBCT and CBT. These include biological factors (Lok et al., 2012, 2013),
cognitive factors (Elgersma et al., 2013), stress (Beshai et al., 2011; Teasdale et al., 2000), family
history of psychopathology (Burcusa and Iacono, 2007), and personality features (Alnaes and
Torgersen, 1997). It has been suggested that the most robust predictors of depressive RR are the
number of prior episodes of depression, and the presence of residual depressive symptoms at
the end of treatment (Burcusa and Iacono, 2007; Keller et al., 1983; Kessing et al., 2004; Mueller
et al., 1999). Previous reviews have synthesized evidence on predictors of RR after various
treatments for depression (e.g. Bockting et al., 2015; Paykel, 2007), but no reviews to date have
focused specifically on predictors of RR after CBT using systematic review or meta-analytic
methods.
There are a number of reasons to focus on the CBT literature. First, as outlined above, CBT
has more enduring effects compared with pharmacotherapy. It is therefore plausible that
CBT works through different mechanisms, and may thus have specific moderators of long-term
effects. Second, CBT is becoming increasingly available in many countries as a first-line
treatment, which raises the need to understand how its durability can be maintained or
enhanced. Third, there is now a critical mass of CBT-oriented research with longitudinal designs,
and where treatments are well described and standardized, thus potentially enabling the
identification of significant RR predictors. On this basis, we aimed to conduct a systematic
review and meta-analysis. We focused on studies that examined predictors of RR in adult patients
who completed acute-phase CBT for major depression, delivered without continuation-phase
interventions.
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Method
Study protocol
The systematic review protocol was registered and published in the International Prospective
Register of Systematic Reviews (PROSPERO) ahead of conducting the review (protocol ID:
PROSPERO 2017:CRD42017057747).
Eligibility criteria
Studies were included if they (1) had an adult (18) sample of participants who were diagnosed
with unipolar major depressive disorder using diagnostic interviews and/or validated depression
case-finding measures, (2) analysed a sample that had completed a course of acute-phase CBT
without continuation-phase interventions such as MBCT or continuation-CBT, (3) were
published in peer-reviewed journals, (4) were written in the English language, (5) were part of
a randomized controlled trial (RCT) or longitudinal cohort study, (6) included a follow-up period
of at least 6 months, and (7) investigated one or more variables as a predictor of RR.
Search strategy
The search strategy was developed using best practice guidelines (Centre for Reviews and
Dissemination, 2009). Four databases (Web of Science, PubMed, PsycINFO, Scopus) were
searched for relevant articles published between January 1990 and March 2017, using variations
of the key words ‘depression’, ‘cognitive behaviour therapy’, ‘relapse’ and ‘predict’.
Selection of articles
The search strategy returned 275 unique titles and abstracts, which were screened for eligibility.
Hand searching was also conducted using the reference lists from previous reviews and included
studies. Further to this, the corresponding authors of eligible articles were contacted and given 4
weeks to recommend relevant articles. This generated 38 new articles, of which only one met the
above eligibility criteria for review. The most common reasons for exclusion during screening
were: populations of adolescents/children; psychological problems other than depression
(e.g. bulimia, psychosis); treatments other than CBT; or the studies did not quantify or report
RR rates. Fifty-nine full-text articles were then assessed for eligibility independently by two
reviewers; any disagreements were discussed and resolved by consensus. Thirteen articles were
identified as eligible for inclusion in the review. Figure 1 shows the PRISMA diagram (Moher
et al., 2009) for the systematic selection of articles.
Quality assessment
Eligible papers were independently assessed for risk of bias by two reviewers, using the Cochrane
Collaboration tool for assessing risk of bias for controlled trials (Higgins et al., 2011) and the
quality assessment tool for observational and cohort studies (U.S. Department of Health and
Human Services, 2014). There were no disagreements in results between the two independent
reviewers.
Data extraction and synthesis
Data were extracted and tabulated using the Cochrane Collaboration Data Collection form
(Higgins and Green, 2011). Two reviewers extracted the data independently. A statistical synthesis
of quantitative data was performed using random effects meta-analysis. In line with standard
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recommendations (Borenstein et al., 2009; Valentine et al., 2010), meta-analysis was restricted to
predictors that were examined across two or more studies, and where relevant significance tests
were reported. To aid interpretation, we transformed relevant inferential statistics (e.g. odds ratios,
chi-squared tests, t-tests, etc.) into correlation coefficients (r) to attain standardization and to
enable meta-analysis (Borenstein et al., 2009). Heterogeneity was examined using the Q and I2
statistics (Higgins et al., 2003). Potential publication bias was examined using regression and
rank-correlation tests for funnel plot asymmetry. Additionally, the Fail-safe N calculation was
performed using Rosenthal’s method (Orwin, 1983). The small number of studies (≤5) entered
into meta-analysis precluded more detailed sub-group or moderator analyses.
It was not possible to apply meta-analytic methods for numerous potential variables due to
under-reporting of statistical information or lack of replication in multiple studies. We therefore
present a detailed narrative synthesis of the results across studies, in order to assess the evidence
concerning variables that were not examined through meta-analysis.
Figure 1. PRISMA diagram presenting search results and article selection procedure.
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Results
Study characteristics
Of the 13 studies eligible for inclusion, nine were RCTs and four were longitudinal cohort studies.
Across these studies, age ranged between 18 and 70 years, with a higher proportion of female
participants. Studies were conducted in the USA, Canada and the Netherlands. Most used a
combination of diagnostic interviews and screening tools to determine a depression diagnosis;
however, four studies only used diagnostic interviews. The total pooled sample size across
included studies was 1219.
Follow-up duration ranged from 12 months to 48 months, with a mean follow-up duration of
20 months. Differences in follow-up duration could potentially influence results, as studies with a
12-month follow-up may show lower rates of RR than those with a 36-month follow-up. However,
after conducting a Pearson’s correlation between RR rates and follow-up duration, we found
no significant association (r = 0.46, p = 0.16). An important discrepancy is that no single or
consistent cut-off was used across studies to demarcate relapse and recurrence events. As shown
in Table 1, the cut-off period (from the time of remission of symptoms) to define ‘relapse’ events
varied from 4 up to 24 months across different studies, thus blurring the boundaries between
these clinical phenomena. As previously discussed, for this reason we refer only to predictors
of RR (relapse and/or recurrence) events, as it is not possible to parse these clinical phenomena
across studies.
The most common statistical technique used to examine potential predictors was a Cox
proportional hazards regression and survival analysis (Cox and Oakes, 1984), which investigates
the effect of several variables on the time to RR. The studies that used this technique collected
measures of depression symptoms and/or diagnosis over the follow-up period either monthly,
bi-monthly or quarterly (see Table 1). Eleven of the selected studies used this technique (Chopra
et al., 2008; Evans et al., 1992; Fresco et al., 2007; Forand and DeRubeis, 2013; Gollan et al., 2006;
Harkness et al., 2012, 2014; Quiring et al., 2002; Segal et al., 2006; Thase et al., 1992, 1996).
Kaplan-Meier survival analysis was also used alongside a Cox proportional hazards regression
in one study (Chopra et al., 2008). A point bi-serial correlation was conducted as the main analysis
by Harkness et al. (2014) and a logistic regression was conducted by Wigman et al. (2014) and
Segal et al. (1999). The samples used in Chopra et al. (2008) and Fresco et al. (2007) were derived
from the study by Segal et al. (2006). Therefore, data from one sample was used in different
analyses resulting in three separate sets of results.
Eight studies used a combined analysis of treatments, where differences in RR were compared
between treatment groups, and if the difference was non-significant they were grouped together
for the investigation of predictors of RR (Chopra et al., 2008; Evans et al., 1992; Gollan et al.,
2006; Harkness et al., 2012, 2014; Segal et al., 1999, 2006; Wigman et al., 2014). Overall, studies that
analysed RR after CBT alone reported a mean RR rate of 29.1%, and studies that grouped different
treatments together (e.g. CBT with pharmacotherapy; CBT with behavioural activation; CBT with
interpersonal therapy and pharmacotherapy) reported a mean RR rate of 28.6%. For clarity, Table 1
presents the total sample sizes for each study (including combined treatments in some studies)
and separately presents the RR rates that are specific to the CBT treatment groups where this
was reported. Meta-analyses reported below present specific sample sizes for the number of cases
(sometimes sub-samples from a wider study) that were followed-up to track RR.
Quality assessment of controlled trials
Sequence generation
Most of the studies did not provide sufficient information to assess whether there was a risk of bias
due to randomization. Most studies lacked a detailed description of the randomization procedures.
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Table 1. Study characteristics
Study
N
subjects
Study of
relapse or
recurrence
Relapse
cut-off
N (%) CBT
subjects
relapsed Age
Depression
measure
Follow-up
N
predictors
Type of
study
Comparison
treatments
Survival or
completer
analyses
Risk of
bias
Length of
follow-up
Time
points
Chopra et al. (2008) 55 Relapse <18 m of
remission
(50.9)* 38.8 (M) DSM-IV 18 months – 3 RCT ADM Completer None
Evans et al. (1992) 44 Relapse <24 m of
remission
2/10 (20) 18–62 RDC;
BDI 20;
HRSD 14
24 months Monthly 48 RCT ADM Survival Authors
as therapists
Forand and
DeRubeis
(2013)
60 Relapse <12 m of
remission
(31.4) 18–70 DSM-IV;
HRSD 20
12 m – 3 RCT ADM Completer Authors
as therapist
Fresco et al. (2007) 237 Relapse <18 m of
remission
– 37 (M) DSM-IV;
HRSD;
BDI-II
18 months – 2 RCT ADM Survival None
Gollan et al. (2006) 151 Relapse <24 m of
remission
(48.6) 21–60 DSM-III-R;
BDI;
HRSD
24 months Every 6 months 6 RCT BA/BATM Completer None
Harkness et al. (2012) 94 Both <4 m of
remission
(18)* 18–60 DSM-IV;
HRSD
12 months Monthly 1 RCT IPT Completer None
Harkness et al. (2014) 108 Both <4 m of
remission
2/22(9) 18–60 DSM-IV;
HRSD
12 months Monthly 3 RCT ADM/IPT Survival None
Quiring et al. (2002) 60 Relapse <24 m of
remission
12/41
(29.3)
20–60 DSM-III-R;
RDC
24 months Quarterly 1 LCS N/A Survival None
Segal et al. (1999) 54 Relapse <6 m of
remission
3/10(30) 18–65 RDC;
HRSD; BDI
13–48
months
– 1 LCS ADM Survival None
Segal et al. (2006) 99 Relapse <18 m of
remission
23/59 (39) 18–65 DSM-IV 18 months Bi-monthly 2 RCT ADM Survival None
Thase et al. (1992) 50 Relapse <12 m of
remission
16/50
(32)
37.3 (M) DSM-III-R;
HRSD
12 months Quarterly 5 LCS n/a Survival None
Thase et al. (1996) 91 Relapse <6 m of
remission
16/71
(23)
38.4 (M) DSM-III-R;
HRSD
36 months Quarterly then
12, 18, 24, 30,
36 months
3 RCT n/a Both None
Wigman et al. (2014) 116 Relapse Range of
2–12 m
between
time points
(17)* 20-63 DSM-IV 24 months 2, 4, 6, 12,
24 months
2 LCS ADM/IPT Completer Sequence
generation
and allocation
concealment/
blinding
M, mean; HRSD, Hamilton Rating Scale for Depression) (Hamilton, 1960); DSM, Diagnostic and Statistics Manual of Mental Disorders; RDC, Research Diagnostic Criteria (Spitzer et al., 1985); BDI, Beck’s Depression
Inventory (Beck et al., 1961); MDD, major depressive disorder; –, information not available; RCT, randomized controlled trial; LCS, longitudinal cohort study; ADM, anti-depressant medication; BA, behavioural
activation; BATM, behavioural activation with automatic thoughts modification; IPT, interpersonal psychotherapy; n/a, not applicable; *this % is from a combined CBT/medication sample as the study did not
report CBT-specific relapse rates.
6
C
aro
lin
e
W
o
jn
aro
w
sk
i
et
a
l.
Allocation concealment and blinding
Due to the nature of the studies included in this review, there is a high risk of bias towards
concealment as participants would be aware if they were receiving CBT or pharmacotherapy, as
would the therapist(s) administering the treatment. Six of the studies do not provide enough
information on the blinding of researchers collecting data, but three studies used research assistants
who were blind to the participant’s condition when collecting data (Evans et al., 1992; Harkness et al.,
2012, 2014).
Incomplete outcome data
As is common in longitudinal studies, there were high rates of attrition. Most of the studies
addressed attrition by either conducting completer analyses (Evans et al., 1992; Gollan et al.,
2006; Harkness et al., 2014; Thase et al., 1996), conducting multiple imputation (Harkness
et al., 2012), or interpolating their data (Forand and DeRubeis, 2013). Three studies do not
provide enough information on how they dealt with missing data (Chopra et al., 2008; Fresco
et al., 2007; Segal et al., 2006).
Selective reporting
There is little evidence of selective reporting within six of the included studies, with the remaining
three showing a low risk of selective reporting as evidenced by published protocols (Chopra et al.,
2008), clear explanations for missing analyses (Forand and DeRubeis, 2013) and stating
hypotheses before treatment began (Harkness et al., 2012).
Other sources of bias
Concerns for other sources of bias come from two studies. In Evans et al. (1992) and Forand and
DeRubeis (2013), the authors of the paper are also the therapists within the study, potentially
leading to researcher allegiance effects. Although it may be coincidental, Evans et al. (1992) also
shows one of the lowest rates of RR among the studies.
Quality assessment for observational studies
All four observational studies (Quiring et al., 2002; Thase et al., 1992; Segal et al., 1999; Wigman
et al., 2014) were rated as being of good quality by the two reviewers.
Rates of RR
The reported rates of depressive RR varied between studies, ranging from 18.5 to 46.5% after
acute-phase CBT. There was an average of 33.4% events within a maximum follow-up period of
36 months.
Predictors of RR
Studies included in this review investigated 62 variables as potential predictors of relapse. Only
four variables were consistently assessed as potential predictors of RR in more than one study
(residual depressive symptoms, prior episodes, cognitive reactivity, marital status). It is possible
that some studies examined a broader range of predictors that were not published in their final
report. Clinical variables (e.g. residual depressive symptoms, prior number of depression episodes)
tended to be studied more often than demographic variables (e.g. age, gender, etc.). We reviewed
all identified (significant and non-significant) predictors, grouped into seven categories: residual
depressive symptoms; prior episodes of depression; cognitive reactivity; stressful life events;
personality factors; clinical and diagnostic factors; demographics. Most of the results are described
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in narrative form, as data in the primary studies did not allow for a quantitative synthesis.
Meta-analyses are presented only for those variables that were examined in more than one study,
and where sufficient quantitative data were available.
Residual depressive symptoms
Five studies examined residual depressive symptoms (e.g. measured using the Beck Depression
Inventory; Beck et al., 1961, or Hamilton Rating Scale for Depression; Hamilton, 1960) at the
end of the acute phase of treatment as a predictor of RR. Four reported statistically significant results
(Evans et al., 1992; Harkness et al., 2014; Thase et al., 1992, 1996) and one reported non-significant
results (Gollan et al., 2006). Meta-analysis results for these studies are displayed in Fig. 2. The pooled
effect was statistically significant, denoting a moderate correlation between residual depressive
symptoms and RR; r = 0.34 (95% CI 0.10, 0.54), p = .01. There was evidence of considerable
heterogeneity; Q = 27.27, d.f. = 4, p < 0.0001; I2 = 85.3% (95% CI 67.6, 93.4). The regression
(t= 0.4729, d.f.= 3, p= 0.67) and rank correlation tests (Kendall’s tau= 0.2000, p= 0.82) for funnel
plot asymmetry were not statistically significant, indicating no evidence of likely publication bias.
According to the fail-safe N, 72 null studies would be needed to overturn this meta-analytic result.
Prior episodes of depression
Five studies examined prior depression episodes or treatments as a predictor of RR. Four reported
statistically significant results (Evans et al., 1992; Chopra et al., 2008; Segal et al., 2006; Thase et al.,
1996) and one reported non-significant results (Thase et al., 1992). Meta-analysis results for these
studies are displayed in Fig. 3, which excludes the study by Chopra et al. (2008) as it is derived from
the sample reported by Segal et al. (2006). The pooled effect was statistically significant, denoting a
small correlation between prior depression episodes and RR; r = 0.19 (0.07, 0.30), p = .002. There
was no significant evidence of heterogeneity; Q =2.64, d.f. = 3, p = 0.45; I2 = 0.0% (95% CI 0.0,
82.6). The regression (t = –0.8810, d.f. = 2, p = 0.47) and rank correlation tests (Kendall’s tau =
–0.33, p = 0.75) for funnel plot asymmetry were not statistically significant and the fail-safe N was 9.
Cognitive reactivity
Seven studies examined responses to the Dysfunctional Attitudes Scale (DAS; Weissman, 1979) as
a predictor of RR. Six studies examined DAS scores as a measure of ‘cognitive reactivity’, following
Figure 2. Random effects meta-analysis: correlations between residual depression and relapse/recurrence.
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mood provocation at the end of treatment (Chopra et al., 2008; Fresco et al., 2007; Gollan et al.,
2006; Segal et al., 1999, 2006; Thase et al., 1992). However, two of these (Chopra et al., 2008;
Fresco et al., 2007) were secondary analyses using the sample from Segal et al. (2006) and were
therefore excluded from meta-analysis. One further study (Evans et al., 1992) was excluded from
meta-analysis as it measured DAS before treatment and did not report relevant statistics; this
study did not find pre-treatment DAS to predict RR. Meta-analysis results for the four included
studies are displayed in Fig. 4. The pooled effect was not statistically significant; r = 0.18 (−0.02,
0.36), p = .08. There was no significant evidence of heterogeneity; Q = 6.81, d.f. = 3, p = 0.08;
I2 = 56.0% (95% CI 0.0, 85.4). The regression (t = 1.40, d.f. = 2, p = 0.30) and rank correlation
tests (Kendall’s tau = 0.33, p = 0.75) for funnel plot asymmetry were not statistically significant
and the fail-safe N was 7.
Figure 3. Random effects meta-analysis: correlations between prior depression episodes and relapse/recurrence.
Figure 4. Random effects meta-analysis: correlations between cognitive reactivity and relapse/recurrence.
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Stressful life events
Participants who reported suffering from childhood maltreatment assessed using the Childhood
Experience of Care and Abuse questionnaire (Bifulco et al., 1994) were significantly more likely to
experience depressive RR with an OR of 2.89 (Harkness et al., 2012). In addition, experiencing a
higher total number of dependent chronic stressors (OR = 1.34) (Harkness et al., 2014) and
experiencing a severe independent life event post-treatment also predicted greater risk of RR
(OR = 1.03) (Harkness et al., 2014); both of these predictors were measured on the Life
Events and Difficulties Schedule (LEDS).
Personality factors
Greater neuroticism scores on the Eysenck Personality Inventory – Neuroticism and Extroversion
Scales (Eysenck, 1968) and greater scores of hopelessness on the Hopelessness Scale (Beck et al.,
1974) also significantly predicted RR (Evans et al., 1992). A dependent personality style on the
Millon Clinical Multiaxial Inventory-II (Millon, 1987) and scoring low on the Pleasant Events
Schedule (PES) (MacPhillamy and Lewisohm, 1982) representing low perceived pleasure
post-treatment also predicted RR (Gollan et al., 2006). Attributional style was not found to be
significantly associated with risk of RR (Evans et al., 1992; Gollan et al., 2006).
Other clinical and diagnostic factors
Quiring et al. (2002) found that as time to treatment entry (time between the onset of depressive
symptoms and the time when treatment begins) increased, time taken to RR also significantly
increased. A slower decrease in symptom scores (i.e. a longer time to treatment response) also
significantly predicted a higher chance of RR (Thase et al., 1992). High levels of intake anxiety
(pre-treatment) on the Beck Anxiety Inventory (BAI; Beck et al., 1988) predicted a shorter time
to RR after completing treatment (OR = 1.08), but post-treatment anxiety levels did not predict
RR (Forand and DeRubeis, 2013). Participants that presented symptoms of a sub-clinical
psychotic experience measured by the Community Assessment of Psychic Experiences (CAPE;
Brenner et al., 2007) and sub-threshold bipolar symptoms measured on the Mood Disorders
Questionnaire (MDQ) (Hirschfeld et al., 2000) were also found to be significantly more prone
to RR with odds ratios of 3.85 and 1.16, respectively (Wigman et al., 2014).
Chopra et al. (2008) found that levels of cortisol post-treatment interacted with patients’
number of prior episodes. Patients with high cortisol levels had similar rates of RR regardless
of prior episodes, but patients with low cortisol levels with two or fewer prior episodes tended
to have lower rates of RR.
Non-significant diagnostic and clinical history features included: age at onset of disorder;
duration of current episode; insidiousness of onset; presence of precipitant; previous treatment
with tricyclics; history of hospitalization; suicidal ideation; history of suicide attempts; history
of alcoholism; history of substance abuse; Research Diagnostic Criteria (RDC) depressive
sub-type; double depression; family history of depression; general level of functioning; biological
functions (Evans et al., 1992); and abnormal sleep patterns (Thase et al., 1996).
Demographics
Thase et al. (1992) found that unmarried participants were more likely to experience RR; however,
Evans et al. (1992) did not find marital status to be a significant predictor. Other demographic
characteristics that were not associated with RR included age, gender, race, employment status,
education, socioeconomic status, and intelligence (Evans et al., 1992).
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Discussion
This study presents the first systematic review and quantitative synthesis of the literature on
predictors of RR (relapse and/or recurrence) after CBT for depression. We specifically chose
to review studies that investigated typical acute-phase CBT, which does not usually include
intensive or lengthy continuation-phase interventions (e.g. MBCT). In the following section,
we discuss key findings, limitations and recommendations for future research.
Several significant predictors were identified across studies; however, the majority were only
tested in single studies and lacked replicated findings. This was particularly the case for most
personality factors, demographics, stressful life events, and clinical and diagnostic factors.
Three variables, however, were examined across multiple studies that reported sufficient data
to enable meta-analysis. Residual depressive symptoms and prior episodes have been previously
cited as the most robust predictors of depressive RR (Burcusa and Iacono, 2007; Keller et al., 1983;
Kessing et al., 2004; Mueller et al., 1999). Our meta-analytic results indicated statistically
significant and moderate correlations (r = 0.34 and r =0.19) between each of these variables
and the risk of RR. Furthermore, we found no evidence of potential publication bias, and the
failsafe N calculations for each of these predictors (72 and 9) indicated that numerous studies
with null findings would be needed to overturn these results. Indices of heterogeneity were high
(I2 = 85.3%) for residual depressive symptoms but not for prior episodes (I2 = 0%). Given that
both meta-analyses included common studies, the considerable difference in heterogeneity may be
related to the way in which residual depressive symptoms were classified across studies
(as opposed to other sources of variability present in the second meta-analysis, such as follow-up
duration, diagnostic methods, study design).
A third commonly cited predictor of depressive RR is cognitive reactivity as measured by the
DAS following a mood induction procedure (Segal et al., 1999, 2006). Several commentaries refer
to this as an established fact (e.g. see Kuyken et al., 2007; Dimidjian et al., 2010), often citing one or
two seminal papers with significant findings. Our meta-analysis does not support this assertion, as
the pooled correlation between cognitive reactivity and RR was not significant, and there was no
evidence of significant heterogeneity in the sample of included studies. This fits with emerging
studies that suggest that mood reactivity may be more relevant than cognitive reactivity in the
prediction of RR (Lethbridge and Allen, 2008; Rucci et al., 2011; van Rijsbergen et al., 2013).
It is possible that the mood induction task itself enables the identification of cases at high risk
of RR, but the risk signals (e.g. high sensitivity to daily stressors, delayed return to euthymic
mood) may be sub-optimally indexed by the DAS measure.
Limitations
A number of limitations are worth considering in relation to the primary studies, and also the
present systematic review methods. As shown in Table 1, at least half of the reviewed studies
applied arbitrary or unconventional operational definitions of relapse, which made it impossible
to clearly disentangle predictors of relapse versus recurrence events.
A major limitation concerns statistical power. The small sample sizes across most of these
studies means that they were highly likely to be underpowered to detect significant factors that
may have a small to moderate effect on the risk of RR. For example, according to Cohen’s sample
size estimation criteria (Cohen, 1992), a simple comparison of means (between cases that RR and
those who do not) in a continuous predictor using ANOVA would require at least 26 RR cases to
detect a large effect size with 80% power, and thus an overall sample of 85 if we assume a RR base
rate of 30%. Using these criteria, 212 participants (64 RR cases) would be necessary to detect a
medium effect size and 1310 participants (393 RR cases) to detect a small effect size. The largest
number of subjects that experienced a RR event in the reviewed studies was 40 (Gollan et al.,
2006), whilst the mean was only 19. We therefore conclude that not even the largest of these
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studies was sufficiently powered to detect a medium effect size, and the fact that many studies
analysed multiple variables further reduces our confidence in their suitability to reliably detect
significant predictors of RR. In this context, meta-analyses are especially important to weigh
up the findings and uncertainty across multiple small studies. As argued by Borenstein et al.
(2009), conclusions drawn from small meta-analyses including two (or more) studies are preferable
to the idiosyncratic interpretations that people may be more likely to make when reading the
results of studies that are not quantitatively pooled and synthesized. Furthermore, over half of
the reviewed studies only reported significant results – there was no mention of variables that
were non-significant predictors of RR in most of the studies. This potentially indicates increased
risk of selective reporting.
The present review had several strengths including the pre-registration of the study protocol;
searches across multiple databases, reference lists and direct requisition to corresponding authors;
double rating of included studies; and quantitative meta-analyses of available data. However,
this review was limited by the exclusions imposed on grey literature, publications in languages
other than English, studies in children and young people, and studies which included a
continuation-phase procedure or intervention. Furthermore, the small number of included studies
did not allow further sub-group and moderator analyses.
Future research
Many studies that were deemed ineligible for this review were well-designed controlled trials with
adequate longitudinal follow-up periods; however, these did not quantify RR events or rates at
follow-up. Typically, trials of CBT tend to analyse follow-up outcomes using continuous outcome
measures (e.g. mean depression severity ratings aggregated at a group-level), which mask RR rates
and make it difficult to assess individual differences in long-term remission. It is advisable for
future trials to report RR rates following conventional definitions to aid comparability. We
recommend that a statistically reliable and clinically significant deterioration in depression
symptoms should be classed as a relapse if it occurs within 12 months after the end of the acute
phase of treatment, and classed as a recurrence if it occurs after 12 months (see Bockting et al.,
2015; Delgadillo et al., 2018).
It is clear that there is a need for further research in this area, testing plausible predictors in
studies that are designed using stringent a priori sample size calculations that would enable the
detection of small to medium effect sizes (as evidenced in our meta-analyses) and expecting a
typical base rate (30%) of RR events. Personality factors (e.g. neuroticism, hopelessness, perceived
pleasure) predicted RR most frequently in the included studies, albeit in single studies. Thus, an
implication for future research would be to investigate the extent to which such personality factors
can be replicated as reliable markers of depressive RR following CBT.
Furthermore, detailed investigations of the mood reactivity hypothesis could be fruitful, for
example including self-reported mood, cortisol levels, and brain imaging data after negative mood
inductions as potential predictors of RR events. It is plausible that mood reactivity may interact with
the presence, chronicity, perceived intensity or control of stressful life events to predict RR (Harkness
et al., 2014). Alternatively, it may be that the presence of residual depressive symptoms and
prior episodes are broadly indicative of a kindling effect, whereby successive depressive episodes
are triggered by progressively milder stressors irrespective of their intensity or controllability
(Monroe and Harkness, 2005). People with certain risk factors (e.g. early childhood adversity, trait
neuroticism) may become highly sensitive to multiple stressors over time. They may therefore show
elevated (residual) symptoms after therapy that become intensified with stressful events, thus
precipitating a cycle of recurrence that in turn undermines their sense of hope and self-efficacy.
Future longitudinal cohort studies could test these assumptions empirically by collecting data on
potential predisposing (e.g. personality, trauma history), prognostic (e.g. prior episodes, residual
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symptoms after CBT, mood reactivity markers), activating (e.g. stressful life events) and mediating
(e.g. self-efficacy, emotion regulation skills, delayed return to euthymic mood) variables.
Clinical implications
It is clear that depression is a highly refractory condition, with approximately one-third of patients
having a clinically significant deterioration of symptoms after CBT. Accordingly, dedicating time to
developing a comprehensive RR prevention blueprint and offering post-treatment booster sessions
for at least 6 months is indicated as part of routine practice. Studies using monthly post-treatment
tracking of symptoms show that the majority (78%) of clinically significant deterioration events
occur within the first 6 months after therapy, so this is a critical period to monitor response to
psychological care (Delgadillo et al., 2018). There are also well-established relapse prevention
interventions that should be offered after patients have completed an acute-phase treatment, such
as continuation-phase CBT (Vittengl et al., 2007) and MBCT (Piet and Hougaard, 2011). As others
have argued (Scott et al., 2003), adjunctive and continuation-phase interventions are costly, but gains
in prevention tend to outweigh the costs of future episodes of care for people that experience RR,
who are often more severely impaired with each subsequent episode. These continuation-phase
treatments could be offered in a stratified care model to maximize cost-effectiveness, selectively
targeting cases with well-established prognostic risk factors (residual depressive symptoms and/or
>3 prior episodes). Cases without such risk factors could be monitored for up to 6 months through
infrequent booster sessions or low-cost telephone contact, to detect early signs of deterioration which
might trigger the use of continuation-phase treatments if necessary.
Conclusions
In summary, at least 30% of patients were found to experience RR (relapse and/or recurrence)
after acute-phase CBT, confirming that depression is a refractory condition, particularly for
patients with prior episodes and with residual depressive symptoms at the end of treatment.
Evidence relating to these risk factors could be used to inform a stratified care model for RR
prevention, prioritizing costly continuation-phase treatments for cases at high risk of RR.
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